Ocular perfusion pressure control during pars plana vitrectomy: testing a novel device

Tommaso Rossi, Giorgio Querzoli, Aldo Gelso, Giampiero Angelini, Alessandro Rossi, Paolo Corazza, Laura Landi, Serena Telani, Guido Ripandelli

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: To study the efficacy of a novel device intended to control infusion pressure based on mean ocular perfusion pressure (MOPP) during pars plana vitrectomy (PPV). Methods: An arm blood pressure cuff connected to a vitrectomy machine calculated mean arterial pressure (MAP), while a pressure sensor close to the infusion trocar measured intraocular pressure (IOP). MOPP was calculated in real time in 36 consecutive patients undergoing PPV, who were divided into two groups. The device lowered IOP every time that calculated MOPP fell below 30 mmHg in the Control ON group (18 patients), while no action was taken in the Control OFF group (18 patients). Results: Baseline IOP and blood pressure were similar between groups. The Control ON group had significantly lower average intraoperative IOP (30.5 ± 2.1 vs. 35.9 ± 6.9 mmHg; p = 0.002) and higher MOPP (56.4 ± 5.9 vs. 49.7 ± 6.1 mmHg) than the Control OFF group. The Control ON group also spent less time at MOPP < 10 mmHg and < 30 mmHg: 0 vs. 3.40 ± 2.38 min (p < 0.001) and 9.91 ± 7.15 vs. 16.13 ± 8.12 min (p = 0.02), respectively. Conclusions: The MOPP control device effectively maintained lower IOP and higher MOPP throughout surgery. It also helped avoid dangerous IOP peaks and MOPP dips, allowing patients to spend less time at MOPP of < 10 and < 30 mmHg.

Original languageEnglish
Pages (from-to)2325-2330
Number of pages6
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume255
Issue number12
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Temazepam
Vitrectomy
Perfusion
Pressure
Equipment and Supplies
Intraocular Pressure
Control Groups
Blood Pressure
Surgical Instruments
Arterial Pressure

Keywords

  • Intraocular pressure
  • Mean arterial pressure
  • Ocular perfusion pressure
  • Pars plana vitrectomy

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Ocular perfusion pressure control during pars plana vitrectomy : testing a novel device. / Rossi, Tommaso; Querzoli, Giorgio; Gelso, Aldo; Angelini, Giampiero; Rossi, Alessandro; Corazza, Paolo; Landi, Laura; Telani, Serena; Ripandelli, Guido.

In: Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 255, No. 12, 01.12.2017, p. 2325-2330.

Research output: Contribution to journalArticle

Rossi, Tommaso ; Querzoli, Giorgio ; Gelso, Aldo ; Angelini, Giampiero ; Rossi, Alessandro ; Corazza, Paolo ; Landi, Laura ; Telani, Serena ; Ripandelli, Guido. / Ocular perfusion pressure control during pars plana vitrectomy : testing a novel device. In: Graefe's Archive for Clinical and Experimental Ophthalmology. 2017 ; Vol. 255, No. 12. pp. 2325-2330.
@article{85fe1f6eb8b04aef9d0879a62ce30139,
title = "Ocular perfusion pressure control during pars plana vitrectomy: testing a novel device",
abstract = "Purpose: To study the efficacy of a novel device intended to control infusion pressure based on mean ocular perfusion pressure (MOPP) during pars plana vitrectomy (PPV). Methods: An arm blood pressure cuff connected to a vitrectomy machine calculated mean arterial pressure (MAP), while a pressure sensor close to the infusion trocar measured intraocular pressure (IOP). MOPP was calculated in real time in 36 consecutive patients undergoing PPV, who were divided into two groups. The device lowered IOP every time that calculated MOPP fell below 30 mmHg in the Control ON group (18 patients), while no action was taken in the Control OFF group (18 patients). Results: Baseline IOP and blood pressure were similar between groups. The Control ON group had significantly lower average intraoperative IOP (30.5 ± 2.1 vs. 35.9 ± 6.9 mmHg; p = 0.002) and higher MOPP (56.4 ± 5.9 vs. 49.7 ± 6.1 mmHg) than the Control OFF group. The Control ON group also spent less time at MOPP < 10 mmHg and < 30 mmHg: 0 vs. 3.40 ± 2.38 min (p < 0.001) and 9.91 ± 7.15 vs. 16.13 ± 8.12 min (p = 0.02), respectively. Conclusions: The MOPP control device effectively maintained lower IOP and higher MOPP throughout surgery. It also helped avoid dangerous IOP peaks and MOPP dips, allowing patients to spend less time at MOPP of < 10 and < 30 mmHg.",
keywords = "Intraocular pressure, Mean arterial pressure, Ocular perfusion pressure, Pars plana vitrectomy",
author = "Tommaso Rossi and Giorgio Querzoli and Aldo Gelso and Giampiero Angelini and Alessandro Rossi and Paolo Corazza and Laura Landi and Serena Telani and Guido Ripandelli",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s00417-017-3799-2",
language = "English",
volume = "255",
pages = "2325--2330",
journal = "Graefe's Archive for Clinical and Experimental Ophthalmology",
issn = "0721-832X",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Ocular perfusion pressure control during pars plana vitrectomy

T2 - testing a novel device

AU - Rossi, Tommaso

AU - Querzoli, Giorgio

AU - Gelso, Aldo

AU - Angelini, Giampiero

AU - Rossi, Alessandro

AU - Corazza, Paolo

AU - Landi, Laura

AU - Telani, Serena

AU - Ripandelli, Guido

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Purpose: To study the efficacy of a novel device intended to control infusion pressure based on mean ocular perfusion pressure (MOPP) during pars plana vitrectomy (PPV). Methods: An arm blood pressure cuff connected to a vitrectomy machine calculated mean arterial pressure (MAP), while a pressure sensor close to the infusion trocar measured intraocular pressure (IOP). MOPP was calculated in real time in 36 consecutive patients undergoing PPV, who were divided into two groups. The device lowered IOP every time that calculated MOPP fell below 30 mmHg in the Control ON group (18 patients), while no action was taken in the Control OFF group (18 patients). Results: Baseline IOP and blood pressure were similar between groups. The Control ON group had significantly lower average intraoperative IOP (30.5 ± 2.1 vs. 35.9 ± 6.9 mmHg; p = 0.002) and higher MOPP (56.4 ± 5.9 vs. 49.7 ± 6.1 mmHg) than the Control OFF group. The Control ON group also spent less time at MOPP < 10 mmHg and < 30 mmHg: 0 vs. 3.40 ± 2.38 min (p < 0.001) and 9.91 ± 7.15 vs. 16.13 ± 8.12 min (p = 0.02), respectively. Conclusions: The MOPP control device effectively maintained lower IOP and higher MOPP throughout surgery. It also helped avoid dangerous IOP peaks and MOPP dips, allowing patients to spend less time at MOPP of < 10 and < 30 mmHg.

AB - Purpose: To study the efficacy of a novel device intended to control infusion pressure based on mean ocular perfusion pressure (MOPP) during pars plana vitrectomy (PPV). Methods: An arm blood pressure cuff connected to a vitrectomy machine calculated mean arterial pressure (MAP), while a pressure sensor close to the infusion trocar measured intraocular pressure (IOP). MOPP was calculated in real time in 36 consecutive patients undergoing PPV, who were divided into two groups. The device lowered IOP every time that calculated MOPP fell below 30 mmHg in the Control ON group (18 patients), while no action was taken in the Control OFF group (18 patients). Results: Baseline IOP and blood pressure were similar between groups. The Control ON group had significantly lower average intraoperative IOP (30.5 ± 2.1 vs. 35.9 ± 6.9 mmHg; p = 0.002) and higher MOPP (56.4 ± 5.9 vs. 49.7 ± 6.1 mmHg) than the Control OFF group. The Control ON group also spent less time at MOPP < 10 mmHg and < 30 mmHg: 0 vs. 3.40 ± 2.38 min (p < 0.001) and 9.91 ± 7.15 vs. 16.13 ± 8.12 min (p = 0.02), respectively. Conclusions: The MOPP control device effectively maintained lower IOP and higher MOPP throughout surgery. It also helped avoid dangerous IOP peaks and MOPP dips, allowing patients to spend less time at MOPP of < 10 and < 30 mmHg.

KW - Intraocular pressure

KW - Mean arterial pressure

KW - Ocular perfusion pressure

KW - Pars plana vitrectomy

UR - http://www.scopus.com/inward/record.url?scp=85029010597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029010597&partnerID=8YFLogxK

U2 - 10.1007/s00417-017-3799-2

DO - 10.1007/s00417-017-3799-2

M3 - Article

C2 - 28887584

AN - SCOPUS:85029010597

VL - 255

SP - 2325

EP - 2330

JO - Graefe's Archive for Clinical and Experimental Ophthalmology

JF - Graefe's Archive for Clinical and Experimental Ophthalmology

SN - 0721-832X

IS - 12

ER -